Clinical Trial Update: Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating intensive neoadjuvant chemotherapy for young patients with high-risk hepatoblastoma undergoing surgical resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatoblastoma
• Liver Cancer

Snippet

Sponsor: University of Leicester | Conditions: Liver Cancer | Phase 2 | Status: UNKNOWN